Through network pharmacology, molecular docking, and molecular dynamics simulation combined with experimental verification, we found that the protection of DHT against SI-AKI may be associated with the downregulation of COX2 to inhibit mitochondrial dysfunction and improve apoptosis. The gene discussed is PTGS2; the disease is acute kidney injury.